Kyle Loftis, founder of 1320Video, has died suddenly, leaving the motorsport community in shock. Loftis' passing follows a ...

Kyle Loftis, founder of 1320Video, has died, leaving a significant impact on motorsports media. His cause of death remains unconfirmed, following a severe crash last December.

Kyle Loftis, the 34-year-old founder of the popular automotive media platform 1320Video has passed away on the night of Tuesday, May 5, 2026. The company confirmed the news on social media the ...

Honda and Aston Martin consider the serious vibration problem resolved with modifications to the engine and chassis. They ...

Sixty-something years ago, carmakers were downplaying their cars’ output to dodge the bounty-hunting insurance companies that sent possies after horsepower as if their incomes depended on it. Nowadays ...

Holley Performance Brands (NYSE: HLLY), home to a portfolio of iconic automotive brands serving enthusiasts across the high-performance aftermarket, has announced its 2026 flagship event season, which ...

Under a research collaboration first established in 2021, Astellas Pharma is moving to license a Dyno Therapeutics gene therapy vehicle—an adeno-associated virus (AAV) capsid engineered for ...

Once you get into performance tuning a two-wheeler, you'll hear a lot of talk about motorcycle dyno tuning. Simply put, a dyno tune is the difference between two performance-tinkered motorcycles off ...

After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. In a new deal potentially worth more than $1 billion, Roche is paying Dyno $50 million upfront to ...

Roche will apply Dyno Therapeutics’ engineered adeno-associated virus (AAV) capsid platform to develop next-generation AAV vectors for gene therapies targeting unspecified neurological diseases, ...

Jim Czekala, from his Facebook profile. Shocking news trickled into the Snow Goer offices this week about the passing of a soft spoken giant in the snowmobile and powersports performance world. Jim ...